NextCure's competitors

NextCure's competitors include MyoKardia, Athersys, Ironwood Pharmaceuticals and Threshold Pharmaceuticals
Add company...
NextCure
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Athersys
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.
Threshold Pharmaceuticals
Threshold Pharmaceuticals is focused on the development of drugs targeting Tumor Hypoxia, a low oxygen condition found in solid tumors.
Founding Date
Founding Date
2015
Founding Date
N/A
Founding Date
1995
Founding Date
N/A
Founding Date
2001
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Beltsville, US HQ
Locations
South San Francisco, US HQ
Locations
Cleveland, US HQ
Canton, US
Locations
Cambridge, US HQ
Locations
South San Francisco, US HQ
Employees
Employees
N/A
Employees
1024% increase
Employees
60
Employees
674
Employees
1512% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
1.7 b
Valuation ($)
340.8 m
Valuation ($)
2.6 b
Valuation ($)
191.2 m
Facebook likes
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
475
Facebook likes
18
Facebook likes
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
387
Twitter followers
953
Twitter followers
3.1 k
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$3.7m (FY, 2017)
Revenue (est.)
$274m (FY, 2016)
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
($46m) (FY, 2017)
Net income
N/A
Net income
($81.7m) (FY, 2016)
Net income
($24.1m) (FY, 2016)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
3 (FY, 2016)
Patents (US)
21 (FY, 2016)
Patents (US)
N/A
Patents (US)
N/A
Patents Issued
Patents Issued
N/A
Patents Issued
4 (Mar, 2018)
Patents Issued
200 (FY, 2016)
Patents Issued
N/A
Patents Issued
N/A

Funding

Total funding raised
Total funding raised
$ 67m
Total funding raised
$ 98m
Total funding raised
$ 9m
Total funding raised
$ 284m
Total funding raised
$ 49.3m
For sources of this data, please see the company profileDownload Excel

View company profiles

MyoKardia
HQ
South San Francisco, US
Employees
102↑ 4% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company
Athersys
HQ
Cleveland, US
Employees
60

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

View company
Ironwood Pharmaceuticals
HQ
Cambridge, US
Employees
674

Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.

View company
Threshold Pharmaceuticals
HQ
South San Francisco, US
Employees
15↓ 12% decrease

Threshold Pharmaceuticals is focused on the development of drugs targeting Tumor Hypoxia, a low oxygen condition found in solid tumors.

View company